Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Recent Pfizer patent reports new treatments for neurodegenerative disorders

Dec. 24, 2008

Supernus initiates phase III trial in refractory partial onset epileptic seizures

Dec. 23, 2008

Positive phase II results reported for C-105 in MS-associated cognitive dysfunction

Dec. 23, 2008

Cadence presents positive top-line results from phase III Acetavance trial

Dec. 23, 2008

Neurobiological Technologies terminates further enrollment in clinical trials of Viprinex

Dec. 22, 2008

Bionomics successfully completes safety studies in animals of antianxiety drug BNC-210

Dec. 22, 2008

KeyNeurotek completes patient recruitment in phase IIa study of KN38-7271 in TBI

Dec. 22, 2008

New agents for psychiatric disorders described in recent Lilly and NeuroSearch patents

Dec. 19, 2008

Recent patents divulge novel analgesic agents

Dec. 19, 2008

Lundbeck initiates phase III trials with desmoteplase in ischemic stroke

Dec. 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...